Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Sysmex America to Spotlight the Future of Hematology Technology During AACC

Published: Tuesday, July 17, 2012
Last Updated: Tuesday, July 17, 2012
Bookmark and Share
Company to showcase new hematology and urinalysis instruments that will represent 80% of the company's future product offering during this week's American Association of Clinical Chemistry (AACC) meeting in Los Angeles.

All of the new instruments are pending FDA 510(k) clearance and are not yet available for sale in the U.S. WAM Select(TM), a new middleware software offering that enables efficiency and control over hematology workflow and results management for small to medium-sized clinical laboratories also will be exhibited. The above instruments and software and cell imaging products can be found at Sysmex's exhibit booth #1347. Sysmex is a global leader in clinical laboratory systemization and solutions, including clinical diagnostics, automation and information systems and services hospitals and healthcare networks, reference laboratories and physicians offices worldwide.

Sysmex in-booth educational presentations, which will feature topics about hematology technology, diabetes management and advanced clinical parameters, among others, are as follows:

Actionable Management Reports: Put Yourself in the Driver's Seat Now!Anne Tate, MT(ASCP)SC, Senior Product Manager, IT Products, Sysmex America, Inc., Mundelein, IL

HbA1c: The Roadmap to Successful Management of the Diabetic PatientMichael Spiekerman M.D., Professor of Pathology and Laboratory Medicines, Texas A&M Health Science Center College of Medicine, Chief, Section of Chemistry Clinical Pathology, Scott & White Healthcare, Temple, TX

Even Small Labs Deserve Auto-validation (WAM Select)Julia Witt, SH(ASCP), Hematology Supervisor - Smith-Glynn-Callaway, Mercy Clinic Laboratory Services, Springfield, MO

Quick Tools to Measure Hematology Lab Productivity and Turn-around TimesAllen A. Wozniak, Sr., MT(ASCP) SC, Sr. Laboratory Consultant, Sysmex America, Inc., Mundelein, IL

The Future of Hematology Technology - Sysmex XN Series*Barbara Connell, MS, MT(ASCP)SH, Sr. Manager, Scientific Marketing, Sysmex America, Inc., Mundelein, IL*Pending FDA 510(k) clearance, not available for sale in the US.

The Measurement of Immature Cells in the Peripheral Blood - A Window to Bone Marrow AssessmentJennifer Marcenelle, RN, MBA, Manager, Clinical Support, Sysmex America, Inc., Mundelein, IL

Sysmex: Shaping the Future of Laboratory ServicesJackie Guenther, MT(ASCP), Sr. Product Manager, Service Marketing, Sysmex America, Inc., Mundelein, IL

Sysmex associates from the U.S., Canada and Latin America will be available to speak with clinical laboratory professionals about the Sysmex hematology and urinalysis instruments, middleware and cell image analysis products at the Sysmex booth #1347.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos